Slottsviken Fastighetsaktiebol operates as a pharmaceutical company. The Company develops and markets, through licensees, pharmaceutical products based on substances extracted from the Podyphyllum plant. Slottsviken product line includes Wartec, for the treatment of warts, and Reumacon used to treat rheumatoid arthritis. The Company markets its products worldwide.
Uppsala Science Park
S-751 83 Uppsala